Sanofi Quarterly Results for Trading Insights

SANOFI • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹120 Cr
QMar 2025
Quarterly Results

Sanofi Quarterly Results Key Highlights

  • Revenue of ₹539 Cr in Mar 2025 (+2.5% vs Sept 2024, -6.9% vs Mar 2024)
  • Net Profit of ₹120 Cr in Mar 2025 (+46.3% vs Sept 2024, -12.4% vs Mar 2024)
  • EBITDA of ₹175 Cr in Mar 2025 (+43.4% vs Sept 2024)
  • Operating Margin of 32.0% in Mar 2025 (+9.0pp vs Sept 2024)
  • Earnings Per Share of ₹51.89 in Mar 2025 (+45.4% vs Sept 2024)

Sanofi Quarterly Results Analysis

Metric Mar 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 QoQ YoY
Revenue (₹ Cr) 539 526 579 503 529 2.5% -6.9%
Net Profit (₹ Cr) 120 82 137 103 91 - -
EBITDA (₹ Cr) 175 122 179 137 132 - -
EPS (₹) 51.89 35.69 59.31 44.81 39.64 - -
Operating Margin (%) 32.0% 23.0% 22.0% 21.0% 23.0% - -

Sanofi Share Price Trend Around Quarterly Results

Visualize Sanofi's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Sanofi

Additional stock information and data for SANOFI

Sanofi share price today
SANOFI earnings multiple
Sanofi yearly highs lows

Profitability Ratios

Profit Margin 22.3%
EBITDA Margin 32.5%
Operating Margin 32.0%
ROE (Annual) 55.7%

Balance Sheet Highlights

Total Assets ₹1,612 Cr
Total Equity ₹861 Cr
Current Assets ₹1,127 Cr
Current Liabilities ₹32 Cr

Cash Flow Analysis

Operating Cash Flow ₹462 Cr
Investing Cash Flow ₹-180 Cr
Financing Cash Flow ₹-392 Cr
Net Cash Flow ₹-111 Cr

Current Market Data

Current Price ₹3463.50
Exchange NSE
Last Updated Apr 09, 2026

Revenue Trend (₹ Cr)

Jun 2024 503
Mar 2024 579
Sept 2024 526
Mar 2025 539

Net Profit Trend (₹ Cr)

Jun 2024 103
Mar 2024 137
Sept 2024 82
Mar 2025 120

Operating Margin Trend (%)

Jun 2024 21.0%
Mar 2024 22.0%
Sept 2024 23.0%
Mar 2025 32.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Sanofi quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1717.1 14,875 3,125 +10.8% - 21.0% 132.1
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5952.5 2,860 689 +7.1% - 24.1% 229.2
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4094.5 3,219 591 +11.3% - 18.4% 233.4
Lupin
Sept 2025 		₹102,578.78 Cr 2295.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1211.9 9,135 1,337 +1.1% - 14.6% 74.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores